arXiv:2606. 20037v1 Announce Type: new Abstract: Alzheimer's disease (AD) is an irreversible neurodegenerative disorder and a leading cause of death worldwide.
By Loukas Ilias, Anthi-Maria Vozinaki, Christos Ntanos, Dimitris Askounis
In longitudinal Alzheimer's disease (AD) diagnosis support, clinical and imaging information is often collected at irregular visits. Integrating these multimodal observations may improve diagnostic assessment, but naive fusion can degrade performance when MRI is noisy or intermittently unavailable.
arXiv:2607. 07091v1 Announce Type: cross Abstract: In longitudinal Alzheimer's disease (AD) diagnosis support, clinical and imaging information is often collected at irregular visits.
By Xinyue Du, Yibo Liu, Zhenglei Zhou, Xuancheng Yao, Weimin Zhong, Qiuhui Chen
The study presents an explainable multimodal deep‑learning framework that combines a 3D CNN for T1‑weighted MRI with a feedforward network for harmonized clinical and demographic data to diagnose Alzheimer’s disease. Using 6,479 ADNI records and 1,703 OASIS‑3 records, the authors compare various model configurations on three‑way and pairwise diagnostic tasks, finding that performance and explanations vary by task, modality, fusion strategy, and cohort. SHAP and Integrated Gradients consistently highlight the MMSE score as the most influential tabular feature, while CAM‑based explanations differ across model setups and cohorts, indicating that explainability is not a stable property under cohort shift.
By Yusuf Brima, Marcellin Atemkeng, Lakshmana Rao Namamula, Antoine Vacavant
arXiv:2609.15888v1 Announce Type: cross
Abstract: Deep networks trained on structural MRI for Alzheimer's disease (AD) staging often reach reasonable accuracy while attending to anatomically irreleva...
By Paul-Gabriel Nicolae, Irina Georgiana Mocanu
The paper introduces a two-stage multi‑modal MRI framework that processes different MRI modalities independently before integrating them through late fusion. First, the model estimates a probability distribution over six developmental stages, then it predicts age using probability‑weighted, stage‑specialized experts. Experiments across nine datasets—from fetal to elderly—show the method outperforms existing baselines, reducing mean absolute error by 13% and 78% in in‑domain and out‑of‑domain settings, and multi‑modal integration yields 12‑13% performance gains. Analysis on ADNI clinical groups indicates that the predicted brain age gap could help characterize Alzheimer’s‑related brain aging.
By Dingyi Zhang, Ruiying Liu, Yun Wang